INS and metabolic dysfunction-associated steatotic liver disease: The supplementation of Saccharomyces boulardii powder for 12 weeks in NAFLD patients significantly decreased the levels of total bilirubin (TBil), aspartate aminotransferase (AST), alanine aminotransferase (ALT), γ-glutamyl transpeptidase (GGT), serum total cholesterol (T-CHO), low-density lipoprotein cholesterol (LDL-C), and fasting insulin [22].